Day: July 21, 2022

Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings

Staff July 21, 2022

The company aims to raise awareness and education about BPH, a common men’s health conditionWAYNE, Pa., July 21, 2022 (GLOBE...

ITM Signs Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177

Staff July 21, 2022

ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Y-mAbs’ Targeted Radionuclide Therapy candidate GD2-SADA: 177Lu-DOTA...

Sandoz Supplemental Biologics License Application accepted by US FDA for biosimilar Hyrimoz® (adalimumab-adaz) high concentration formulation (HCF)

Staff July 21, 2022

Submission supported by comprehensive analytical data package and clinical Phase I pharmacokinetics bridging study Proposed Hyrimoz® HCF would help expand...

[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023

Staff July 21, 2022

Christoph Franz has decided not to seek re-election to the Board of Directors at the Annual General Meeting (AGM) in...

Day: July 21, 2022

Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings

ITM Signs Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177

Sandoz Supplemental Biologics License Application accepted by US FDA for biosimilar Hyrimoz® (adalimumab-adaz) high concentration formulation (HCF)

[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023

argenx to Report Half Year 2022 Financial Results and Second Quarter Business Update on July 28, 2022

Addex Completes Reduction in Nominal Value of Shares

Addex Provides Corporate Update and Financial Guidance

[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022

Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

Sotera Health Announces Second-Quarter 2022 Earnings Release Date

Delota Provides Corporate Update and Early Redemption of Convertible Debentures

Laxco, Inc. Announces the Launch of Accuva LEAP: A Revolutionary Imaging System Engineered for Tomorrow’s Research

LABORATORY TECHNOLOGY EXPERT MAKES MAJOR ANNOUNCEMENT

Healthee raises $50M to redefine the future of health benefits

Turacoz Group Drives Strategic Dialogue on Content Innovation at Reuters Events Pharma 2025 in Barcelona

You may have missed